CVM- Q1 Data Release and Beautiful Wedge Forming
CVM has an update coming up on their drug for head and neck cancer, Multikine. This alone tells you that this is a good stock to own in March. The fact that they are forming a bullish flag formation already is a little surprising, but I will definitely enter this week. Look to hold throughout March and watch out for the press release. Good luck!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.